Nuvig secures $161m financing to support clinical studies for NVG-2089
Norwest Venture Partners, Sanofi Ventures, and Blue Owl Healthcare Opportunities co-led the financing.
Autoimmune Disorders
Kezar struck again with second FDA hold
RAPT Therapeutics shares tumble by 48% after zelnecirnon programme cull
Priovant mulls broad autoimmune indications for brepocitinib
Adicet Bio begins enrolling subjects in Phase I trial of autoimmune disease therapy
UCB and Biogen lupus drug succeeds in Phase III, but data yet to be released
Immunovant touts positive Phase II batoclimab data as IMVT-1402 also progresses
Aurinia doses first subject in Phase Ia trial of AUR200 for autoimmune diseases
